will be organized by
National Institute for Laser, Plasma and Radiation Physics, Magurele – Bucharest, Romania &
Alexandru Ioan Cuza University of Iasi, Iasi, Romania
WELCOME TO THE ICPIG 2025 – JULY 20TH/25TH – AIX EN PROVENCE, FRANCE
The International Conference on Phenomena in Ionized Gases (ICPIG), now in its XXXVI edition, since 1953 has been a forum for the discussion of nearly all fields of plasma science, covering modelling and experiments, from the fundamentals of elementary processes, basic data and discharge physics (including transport and interaction with walls), to applications. Topics include low and high pressure thermal and non-thermal plasmas including non-thermal plasmas in fusion devices and atmospheric and stellar plasmas, from modelling to diagnostics, from surface processing to plasma medicine, environmental protection and pollution control, plasma aerodynamics…
More info here
Join the event to discover the range of services at your disposal to ease the first steps of the path to market of your Pathfinder results. The event will be opened by the EIC Board President providing an opportunity to participants to hear about the EIC Board, the role and vision of the EIC Board President. Feature sessions will cover the EIC Business Acceleration, the EIC Women Leadership Programme, the Horizon Results Booster, the European Union Intellectual Property Office (EUIPO), the European IP Helpdesk, the European Medicines Agency (EMA) services, and few more. Participants will learn on when, for what, who and how one can apply to a given service as well as on the expected outputs. You will also hear about the proactive project and portfolio management implemented by EIC Programme Manager with the EIC Pathfinder PO support. During the event, you will have the opportunity to ask questions to the speakers via Slido and will learn for example but not exclusively on:
Vasileios Vavourakis, Associate Professor at the University of Cyprus and Honorary Senior Lecturer at the University College London, announced their recent work in computational modelling (which is also referred as _in silico_ modelling) and medical image analysis towards building a digital tool forecasting lung cancer patient outcome after radiation therapy.
The four-year joint effort of his group (https://in-silico-modelling.ucy.ac.cy) with clinical experts from the Bank of Cyprus Oncology Centre (https://www.bococ.org.cy/en) culminated in a peer-reviewed research article in the Royal Society Interface journal. The manuscript is open-accessible from here
12-13 May, 2025
The 4th Workshop on FAIR Data in Plasma Science (FDPS-IV) will be held on 12-13 May, 2025 at the INP in Greifswald, Germany. The event will also offer the option for virtual participation. The workshop is a continuation of annual events on research data management in the low-temperature plasma (LTP) community in the past years. It aims to inform about current developments and to strengthen community exchange on this topic.
The workshop will be held as a hybrid meeting. The on-site event will take place at
Leibniz Institute for Plasma Science and Technology (INP)
Felix-Hausdorff-Str. 2
17489 Greifswald
Germany
For more information and Registration application, please, visit:
September 8th – September 13th 2024
Portorož-Portorose, Slovenia
The 10th International Conference on Plasma Medicine (ICPM10), together with 9th International Workshop on Plasma for Cancer Treatment (IWPCT) will be held in Portorož, Slovenia, from Sep. 8th to Sep. 13th 2024. It will be an on-site conference in LifeClass Hotels & Spa Portorož (Hotels Slovenia 5*, Riviera 4*, Grand Hotel Portorož 4*), in the Portorož downtown area on the beach.
Senior Principal Research Scientist, Neuroscience Research Australia and Professor, University of New South Wales (UNSW), Sydney, Australia
Murray B. Sachs Professor of Biomedical Engineering and Medicine, Professor of Medicine, Professor of Applied Mathematics and Statistics
Department of Biomedical Engineering, Johns Hopkins University, Baltimore, USA
Director of Research INRIA (French National Institut(ion) for Research in Computer Science and Control), Rocquencourt, France
Professor of Computational Science and Engineering, Informatics Institute, University of Amsterdam
Krakow, Poland
The annual meeting of the COST action PRECISION-BTC-NETWORK (Management Committee and General Meeting) to be held jointly with the bi-annual ENS-CCA conference. This meeting will focus on biliary tract cancer, covering a wide range of topics including adjuvant treatment, immunotherapy, biomarkers for patients’ selection, the role of artificial intelligence in guiding treatment choice, discussion of the data from the large international European registry on bile duct cancers, development of novel therapeutics with a focus on targeting the microenvironment and the immune system.
The ESBiomech 2024 scientific programme will include keynote speakers, podium and posters contributions on the latest research developments on all branches of biomechanics.
All traditional ESB sessions and activities will be organized to their full extend – a rich scientific program, interactive and mentoring sessions, students activities, exhibition and networking events.
We are looking forward to welcome you in the beautiful city of Edinburgh!
The Council conclusions also recognise the pivotal role of digital technologies, AI and health data in enhancing patient care, advancing research, and shaping public health policy. Digital policy has been evolving rapidly in the last five years, necessitating a period of adjustment for companies to fully comply with new EU regulations. To ensure smooth implementation, harmonisation in application between Member States and clear guidance on overlapping requirements will be essential. As we move into the next phase when the new requirements start applying to medical technologies, we stress the importance of wide inclusion of all healthcare ecosystem
stakeholders in their implementation.
Building resilient health systems requires a robust, competitive, and innovation-driven industry. While EU regulations promote stability, trust and access to the world’s second-largest medical technology market, they have also raised barriers to entry and present risks of over-regulation. It is critical to adjust the regulatory environment so that it fosters innovation and supports manufacturers of any size, including SMEs, which are crucial for fostering a resilient and dynamic health sector. MedTech Europe hopes to work closely with Member States to find solutions that harmonise the current system and maintain Europe’s competitiveness and attractiveness for innovation to serve patients and health systems in Europe.
Setting the direction for EU health policy over the next five years, Member States now need to be ambitious in implementing their conclusions. Now is the time to make our health systems more patient-centric, digitally advanced, resilient and sustainable.
